Meddy El Alaoui
Chief Executive Officer AbTx
Meddy El Alaoui is the CEO of AbTx and the Scientific Director of COVALAB, bringing over eight years of leadership in biotechnology. His career is dedicated to advancing targeted cancer therapies, beginning with his postdoctoral research at the Centre Léon Bérard and the University of Cambridge, where he focused on developing precise immunotherapies for breast cancer to minimize side effects. Previously, he served as a teaching assistant in biochemistry at Université Claude Bernard Lyon 1. Meddy combines deep scientific expertise with a visionary approach to creating more effective and safer therapeutic solutions.
